Back to MORGAN STANLEY MORGAN STANLEY

NBIXNBIX
8 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in NEUROCRINE BIOSCIENCES INC

MORGAN STANLEY holds 1.2M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $160.6M as of 2026-Q1. The position was increased (+0.8% shares). NBIX represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$160.6M

Current Shares

1.2M

Total Value Change

-$52.1M

Total Shares Change

-325,673

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.2M
+0.8%
$160.6M0.0%$131.14
31
2025-Q4
Decreased
1.2M
-33.8%
$171.5M0.0%$140.95
0
2025-Q3
Increased
1.8M
+0.4%
$256.5M0.0%$140.27
31
2025-Q2
Increased
1.8M
+19.9%
$228.7M0.0%$125.42
36
2025-Q1
Decreased
1.5M
-3.5%
$167.9M0.0%$113.16
0
2024-Q4
Increased
1.6M
+16.6%
$214.8M0.0%$137.06
36
2024-Q3
Decreased
1.3M
-12.7%
$155.5M0.0%$115.06
0
2024-Q2
New
1.5M
-
$212.7M0.0%$137.67
42

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used